Centerpoint Advisors LLC Sells 295 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Centerpoint Advisors LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 17.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,388 shares of the healthcare conglomerate’s stock after selling 295 shares during the quarter. Centerpoint Advisors LLC’s holdings in UnitedHealth Group were worth $702,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the company. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the fourth quarter worth approximately $30,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group during the 3rd quarter worth approximately $37,000. DecisionPoint Financial LLC lifted its holdings in UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after purchasing an additional 62 shares during the last quarter. Highline Wealth Partners LLC bought a new position in shares of UnitedHealth Group in the third quarter valued at about $55,000. Finally, Legacy Investment Solutions LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth about $57,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on UNH. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Barclays decreased their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $629.32.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 1.4 %

Shares of NYSE UNH opened at $523.48 on Tuesday. The company has a market cap of $481.75 billion, a price-to-earnings ratio of 33.77, a PEG ratio of 1.45 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a 50-day moving average price of $523.11 and a two-hundred day moving average price of $563.00. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 earnings per share. The company’s revenue was up 6.8% on a year-over-year basis. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.